Phase I Study of the Proteosome Inhibitor CEP 18770 in Patients With Solid Tumours or Non-Hodgkin's Lymphomas

Clinical trial NCT00572637 · COMPLETED

Trial details

NCT number: NCT00572637
Sponsor: Ethical Oncology Science
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumors Lymphoma, Non-Hodgkin

Start date: 2007-11-01
Primary completion: 2010-03-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.